| Expression of connective tissue growth factor in human renal fibrosis Y Ito, J Aten, RJ Bende, BS Oemar, TJ Rabelink, JJ Weening, ... Kidney international 53 (4), 853-861, 1998 | 836 | 1998 |
| Synergy Between Tumor Suppressor APC and the β-Catenin-Tcf4 Target Tcf1 J Roose, G Huls, M Beest, P Moerer, K Horn, R Goldschmeding, ... Science 285 (5435), 1923-1926, 1999 | 649 | 1999 |
| Gene regulation of connective tissue growth factor: new targets for antifibrotic therapy? IE Blom, R Goldschmeding, A Leask Matrix Biology 21 (6), 473-482, 2002 | 533 | 2002 |
| Wegener's granulomatosis autoantibodies identify a novel diisopropylfluorophosphate-binding protein in the lysosomes of normal human neutrophils. R Goldschmeding, CE Van der Schoot, D ten Bokkel Huinink, CE Hack, ... The Journal of clinical investigation 84 (5), 1577-1587, 1989 | 494 | 1989 |
| Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy KM Dolman, AEGK von dem Borne, R Goldschmeding, RDB Gans, ... The Lancet 342 (8872), 651-652, 1993 | 438 | 1993 |
| What is orbital pseudotumor? I Mombaerts, R Goldschmeding, RO Schlingemann, L Koornneef Survey of ophthalmology 41 (1), 66-78, 1996 | 384 | 1996 |
| CTGF expression in mesangial cells: involvement of SMADs, MAP kinase, and PKC Y Chen, IE Blom, S Sa, R Goldschmeding, DJ Abraham, A Leask Kidney international 62 (4), 1149-1159, 2002 | 322 | 2002 |
| Proposal for a unified CCN nomenclature DR Brigstock, R Goldschmeding, KI Katsube, SCT Lam, LF Lau, K Lyons, ... Molecular Pathology 56 (2), 127-128, 2003 | 288 | 2003 |
| Connective tissue growth factor (CTGF) from basics to clinics Y Ramazani, N Knops, MA Elmonem, TQ Nguyen, FO Arcolino, ... Matrix Biology 68, 44-66, 2018 | 279 | 2018 |
| Diverse origins of the myofibroblast—implications for kidney fibrosis LL Falke, S Gholizadeh, R Goldschmeding, RJ Kok, TQ Nguyen Nature Reviews Nephrology 11 (4), 233-244, 2015 | 275 | 2015 |
| The angio-fibrotic switch of VEGF and CTGF in proliferative diabetic retinopathy EJ Kuiper, FA Van Nieuwenhoven, MD de Smet, JC van Meurs, ... PloS one 3 (7), e2675, 2008 | 275 | 2008 |
| Association of autoantibodies to myeloperoxidase with different forms of vasculitis JWC Tervaert, R Goldschmeding, JD Elema, PC Limburg, ... Arthritis & Rheumatism 33 (8), 1264-1272, 1990 | 267 | 1990 |
| FAN1 mutations cause karyomegalic interstitial nephritis, linking chronic kidney failure to defective DNA damage repair W Zhou, EA Otto, A Cluckey, R Airik, TW Hurd, M Chaki, K Diaz, FP Lach, ... Nature genetics 44 (8), 910-915, 2012 | 261 | 2012 |
| Autoantibodies against myeloid lysosomal enzymes in crescentic glomerulonephritis CT JW Kidney Int. 37, 799-806, 1990 | 250 | 1990 |
| Bone-marrow-derived cells contribute to glomerular endothelial repair in experimental glomerulonephritis MB Rookmaaker, AM Smits, H Tolboom, K Van't Wout, AC Martens, ... The American journal of pathology 163 (2), 553-562, 2003 | 242 | 2003 |
| Connective tissue growth factor and cardiac fibrosis A Daniels, M Van Bilsen, R Goldschmeding, GJ Van Der Vusse, ... Acta physiologica 195 (3), 321-338, 2009 | 231 | 2009 |
| Determination of human platelet antigen frequencies in the Dutch population by immunophenotyping and DNA (allele-specific restriction enzyme) analysis S Simsek, NM Faber, PM Bleeker, ABJ Vlekke, E Huiskes, ... Blood 81 (3), 835-840, 1993 | 226 | 1993 |
| Are systemic corticosteroids useful in the management of orbital pseudotumors? I Mombaerts, RO Schlingemann, R Goldschmeding, L Koornneef Ophthalmology 103 (3), 521-528, 1996 | 214 | 1996 |
| Focal segmental glomerulosclerosis in a patient homozygous for a CD2AP mutation MM Löwik, P Groenen, I Pronk, MR Lilien, R Goldschmeding, HB Dijkman, ... Kidney international 72 (10), 1198-1203, 2007 | 198 | 2007 |
| Targeting CTGF, EGF and PDGF pathways to prevent progression of kidney disease HM Kok, LL Falke, R Goldschmeding, TQ Nguyen Nature Reviews Nephrology 10 (12), 700-711, 2014 | 190 | 2014 |
